(Q42831020)

English

Inhibition of poly adenosine diphosphate-ribose polymerase decreases hepatocellular carcinoma growth by modulation of tumor-related gene expression

scientific article published on January 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 November 2017

Inhibition of poly adenosine diphosphate-ribose polymerase decreases hepatocellular carcinoma growth by modulation of tumor-related gene expression (English)

1 reference

Europe PubMed Central

8 November 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

David Martín-Oliva

7

1 reference

Europe PubMed Central

8 November 2017

author name string

Rosa Quiles-Perez

1

1 reference

Europe PubMed Central

8 November 2017

José Antonio Muñoz-Gámez

2

1 reference

Europe PubMed Central

8 November 2017

Angeles Ruiz-Extremera

3

1 reference

Europe PubMed Central

8 November 2017

Francisco O'Valle

4

1 reference

Europe PubMed Central

8 November 2017

Laura Sanjuán-Nuñez

5

1 reference

Europe PubMed Central

8 November 2017

Ana Belén Martín-Alvarez

6

1 reference

Europe PubMed Central

8 November 2017

Trinidad Caballero

8

1 reference

Europe PubMed Central

8 November 2017

Paloma Muñoz de Rueda

9

1 reference

Europe PubMed Central

8 November 2017

Josefa León

10

1 reference

Europe PubMed Central

8 November 2017

Raúl Gonzalez

11

1 reference

Europe PubMed Central

8 November 2017

Jordi Muntané

12

1 reference

Europe PubMed Central

8 November 2017

Francisco Javier Oliver

13

1 reference

Europe PubMed Central

8 November 2017

Javier Salmerón

14

1 reference

Europe PubMed Central

8 November 2017

language of work or name

0 references

publication date

1 January 2010

1 reference

Europe PubMed Central

8 November 2017

1 reference

Europe PubMed Central

8 November 2017

51

1 reference

Europe PubMed Central

8 November 2017

255-266

1 reference

Europe PubMed Central

8 November 2017

1

1 reference

Europe PubMed Central

8 November 2017

Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23249

21 January 2018

DNA-independent PARP-1 activation by phosphorylated ERK2 increases Elk1 activity: a link to histone acetylation.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23249

21 January 2018

Modulation of transcription by PARP-1: consequences in carcinogenesis and inflammation.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23249

21 January 2018

Poly(ADP‐ribose) and carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23249

21 January 2018

Role of the peroxynitrite-poly (ADP-ribose) polymerase pathway in the pathogenesis of liver injury

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23249

21 January 2018

Poly(ADP-ribose) polymerase-1 inhibition increases expression of heat shock proteins and attenuates heat stroke-induced liver injury

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23249

21 January 2018

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23249

21 January 2018

DNA vector-based RNAi approach for stable depletion of poly(ADP-ribose) polymerase-1.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23249

21 January 2018

Crosstalk between PARP-1 and NF-kappaB modulates the promotion of skin neoplasia

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23249

21 January 2018

Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23249

21 January 2018

PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23249

21 January 2018

Molecular targeted therapies in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23249

21 January 2018

Therapeutic treatment with poly(ADP-ribose) polymerase inhibitors attenuates the severity of acute pancreatitis and associated liver and lung injury.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23249

21 January 2018

The therapeutic potential of poly(ADP-ribose) polymerase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23249

21 January 2018

Shock, inflammation and PARP.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23249

21 January 2018

Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23249

21 January 2018

Loss of Parp-1 affects gene expression profile in a genome-wide manner in ES cells and liver cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23249

21 January 2018

Transcriptional control by PARP-1: chromatin modulation, enhancer-binding, coregulation, and insulation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23249

21 January 2018

Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23249

21 January 2018

EGFR and VEGFR as potential target for biological therapies in HCC cells.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23249

21 January 2018

From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23249

21 January 2018

Prognostic significance of HIF-2alpha/EPAS1 expression in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23249

21 January 2018

Involvement of the vascular endothelial growth factor receptor-1 in murine hepatocellular carcinoma development.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23249

21 January 2018

High-resolution analysis of genomic profiles of hepatocellular carcinoma cells with differential osteopontin expression

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23249

21 January 2018

Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23249

21 January 2018

Parp-1 deficiency implicated in colon and liver tumorigenesis induced by azoxymethane.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23249

21 January 2018

Parp-1 deficiency does not enhance liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline in mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23249

21 January 2018

PARP activation and the alteration of vasoactive factors and extracellular matrix protein in retina and kidney in diabetes.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23249

21 January 2018

Poly(ADP-ribose) polymerase expression in kidney transplantation: from alfa (alpha) to Omega (Omega).

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23249

21 January 2018

Inhibition of Poly(ADP-Ribose) Polymerase Modulates Tumor-Related Gene Expression, Including Hypoxia-Inducible Factor-1 Activation, during Skin Carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23249

21 January 2018

Vascular endothelial growth factor, its receptor Flk-1, and hypoxia inducible factor-1alpha are involved in malignant transformation in dysplastic nodules of the liver

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23249

7 January 2021

based on heuristic

inferred from DOI database lookup

Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23249

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.23249

1 reference

Europe PubMed Central

8 November 2017

1 reference

Europe PubMed Central

8 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42831020&oldid=1971501131"